These novel treatments, Tirzepatide , represent a significant advancement in addressing metabolic dysfunction and possibly related disorders. They all are classified as GLP-1 pathway agonists , signifying they function to emulate the endogenous GLP-1 peptide, boosting glucose secretion and suppressing hunger . Although Tirzepatide each one works la